[日本語] English
- PDB-1mnt: SOLUTION STRUCTURE OF DIMERIC MNT REPRESSOR (1-76) -

+
データを開く


IDまたはキーワード:

読み込み中...

-
基本情報

登録情報
データベース: PDB / ID: 1mnt
タイトルSOLUTION STRUCTURE OF DIMERIC MNT REPRESSOR (1-76)
要素MNT REPRESSOR
キーワードTRANSCRIPTION REGULATION
機能・相同性
機能・相同性情報


regulation of DNA-templated transcription / DNA binding
類似検索 - 分子機能
Bacteriophage P22, Mnt / Regulatory protein Mnt / Arc-like DNA binding domain / Arc-like DNA binding domain / Met repressor-like / Arc Repressor Mutant / Arc-type ribbon-helix-helix / Ribbon-helix-helix / Orthogonal Bundle / Mainly Alpha
類似検索 - ドメイン・相同性
Regulatory protein mnt
類似検索 - 構成要素
生物種Enterobacteria phage P22 (ファージ)
手法溶液NMR
データ登録者Burgering, M.J.M. / Boelens, R. / Gilbert, D.E. / Breg, J.N. / Knight, K.L. / Sauer, R.T. / Kaptein, R.
引用
ジャーナル: Biochemistry / : 1994
タイトル: Solution structure of dimeric Mnt repressor (1-76).
著者: Burgering, M.J. / Boelens, R. / Gilbert, D.E. / Breg, J.N. / Knight, K.L. / Sauer, R.T. / Kaptein, R.
#1: ジャーナル: J.Biomol.NMR / : 1993
タイトル: Observation of Inter-Subunit Noes in a Dimeric P22 Mnt Repressor Mutant by a Time-Shared [15N, 13C] Double Half Filter Technique
著者: Burgering, M.J.M. / Boelens, R. / Kaptein, R.
#2: ジャーナル: Nature / : 1990
タイトル: Structure of Arc Repressor in Solution: Evidence for a Family of B-Sheet DNA-Binding Protein
著者: Breg, J.N. / Van Opheusden, J.H.J. / Burgering, M.J.M. / Boelens, R. / Kaptein, R.
#3: ジャーナル: Biochemistry / : 1988
タイトル: The Mnt Repressor of Bacteriophage P22: Role of the C-Terminal Residues in Operator Binding and Tetramer Formation
著者: Knight, K.L. / Sauer, R.T.
履歴
登録1994年6月28日処理サイト: BNL
改定 1.01994年9月30日Provider: repository / タイプ: Initial release
改定 1.12008年3月24日Group: Version format compliance
改定 1.22011年7月13日Group: Version format compliance
改定 1.32022年2月23日Group: Database references / Derived calculations / Other
カテゴリ: database_2 / pdbx_database_status ...database_2 / pdbx_database_status / pdbx_struct_assembly / pdbx_struct_oper_list
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_database_status.process_site
改定 1.42024年5月22日Group: Data collection / カテゴリ: chem_comp_atom / chem_comp_bond

-
構造の表示

構造ビューア分子:
MolmilJmol/JSmol

ダウンロードとリンク

-
集合体

登録構造単位
A: MNT REPRESSOR
B: MNT REPRESSOR


分子量 (理論値)分子数
合計 (水以外)17,6522
ポリマ-17,6522
非ポリマー00
00
1


  • 登録構造と同一
  • 登録者が定義した集合体
タイプ名称対称操作
identity operation1_555x,y,z1
Atom site foot note1: HIS A 6 - PHE A 7 MODEL 1 OMEGA = 115.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
2: PHE A 9 - ARG A 10 MODEL 1 OMEGA = 239.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
3: PHE A 21 - ARG A 22 MODEL 1 OMEGA = 106.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
4: ALA A 23 - GLU A 24 MODEL 1 OMEGA = 121.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
5: GLU A 24 - ALA A 25 MODEL 1 OMEGA = 24.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
6: ASN A 26 - GLY A 27 MODEL 1 OMEGA = 148.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
7: ARG A 28 - SER A 29 MODEL 1 OMEGA = 241.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
8: SER A 29 - MET A 30 MODEL 1 OMEGA = 214.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
9: ASN A 31 - SER A 32 MODEL 1 OMEGA = 144.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
10: SER A 43 - LYS A 44 MODEL 1 OMEGA = 140.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
11: LYS A 44 - PRO A 45 MODEL 1 OMEGA = 61.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
12: PRO A 45 - SER A 46 MODEL 1 OMEGA = 142.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
13: VAL A 48 - THR A 49 MODEL 1 OMEGA = 347.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
14: THR A 49 - GLY A 50 MODEL 1 OMEGA = 135.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
15: GLY A 50 - TYR A 51 MODEL 1 OMEGA = 353.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
16: ASN A 53 - ASP A 54 MODEL 1 OMEGA = 258.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
17: ALA A 55 - GLU A 56 MODEL 1 OMEGA = 82.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
18: LEU A 58 - ALA A 59 MODEL 1 OMEGA = 141.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
19: PHE B 9 - ARG B 10 MODEL 1 OMEGA = 350.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
20: SER B 29 - MET B 30 MODEL 1 OMEGA = 226.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
21: ASN B 31 - SER B 32 MODEL 1 OMEGA = 141.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
22: SER B 43 - LYS B 44 MODEL 1 OMEGA = 149.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
23: PRO B 45 - SER B 46 MODEL 1 OMEGA = 135.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
24: VAL B 48 - THR B 49 MODEL 1 OMEGA = 357.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
25: ARG B 52 - ASN B 53 MODEL 1 OMEGA = 212.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
26: ASP B 54 - ALA B 55 MODEL 1 OMEGA = 117.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
27: ALA B 55 - GLU B 56 MODEL 1 OMEGA = 137.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
28: LEU B 58 - ALA B 59 MODEL 1 OMEGA = 131.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
29: SER B 63 - GLU B 64 MODEL 1 OMEGA = 119.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
30: GLU B 64 - LEU B 65 MODEL 1 OMEGA = 127.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
31: PHE A 9 - ARG A 10 MODEL 2 OMEGA = 347.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
32: ARG A 16 - GLU A 17 MODEL 2 OMEGA = 121.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
33: SER A 29 - MET A 30 MODEL 2 OMEGA = 216.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
34: ASN A 31 - SER A 32 MODEL 2 OMEGA = 145.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
35: SER A 43 - LYS A 44 MODEL 2 OMEGA = 147.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
36: PRO A 45 - SER A 46 MODEL 2 OMEGA = 145.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
37: VAL A 48 - THR A 49 MODEL 2 OMEGA = 5.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
38: THR A 49 - GLY A 50 MODEL 2 OMEGA = 143.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
39: GLY A 50 - TYR A 51 MODEL 2 OMEGA = 148.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
40: ASN A 53 - ASP A 54 MODEL 2 OMEGA = 12.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
41: ASP A 54 - ALA A 55 MODEL 2 OMEGA = 124.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
42: ALA A 55 - GLU A 56 MODEL 2 OMEGA = 99.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
43: ARG A 57 - LEU A 58 MODEL 2 OMEGA = 148.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
44: LEU A 58 - ALA A 59 MODEL 2 OMEGA = 148.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
45: ALA B 1 - ARG B 2 MODEL 2 OMEGA = 350.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
46: HIS B 6 - PHE B 7 MODEL 2 OMEGA = 116.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
47: PHE B 9 - ARG B 10 MODEL 2 OMEGA = 233.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
48: SER B 29 - MET B 30 MODEL 2 OMEGA = 216.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
49: ASN B 31 - SER B 32 MODEL 2 OMEGA = 144.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
50: VAL B 38 - GLN B 39 MODEL 2 OMEGA = 149.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
51: PRO B 45 - SER B 46 MODEL 2 OMEGA = 131.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
52: VAL B 48 - THR B 49 MODEL 2 OMEGA = 246.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
53: ASN B 53 - ASP B 54 MODEL 2 OMEGA = 14.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
54: ASP B 54 - ALA B 55 MODEL 2 OMEGA = 143.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
55: ALA B 55 - GLU B 56 MODEL 2 OMEGA = 89.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
56: LEU B 58 - ALA B 59 MODEL 2 OMEGA = 144.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
57: SER B 63 - GLU B 64 MODEL 2 OMEGA = 121.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
58: ASP A 3 - ASP A 4 MODEL 3 OMEGA = 39.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
59: HIS A 6 - PHE A 7 MODEL 3 OMEGA = 137.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
60: PHE A 9 - ARG A 10 MODEL 3 OMEGA = 130.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
61: SER A 29 - MET A 30 MODEL 3 OMEGA = 225.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
62: ASN A 31 - SER A 32 MODEL 3 OMEGA = 143.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
63: LYS A 44 - PRO A 45 MODEL 3 OMEGA = 47.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
64: GLY A 50 - TYR A 51 MODEL 3 OMEGA = 3.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
65: ARG A 52 - ASN A 53 MODEL 3 OMEGA = 211.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
66: ASN A 53 - ASP A 54 MODEL 3 OMEGA = 98.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
67: ASP A 54 - ALA A 55 MODEL 3 OMEGA = 111.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
68: ALA A 55 - GLU A 56 MODEL 3 OMEGA = 112.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
69: ARG A 57 - LEU A 58 MODEL 3 OMEGA = 143.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
70: LEU A 58 - ALA A 59 MODEL 3 OMEGA = 136.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
71: ASP A 60 - GLU A 61 MODEL 3 OMEGA = 145.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
72: GLU A 64 - LEU A 65 MODEL 3 OMEGA = 141.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
73: LEU A 65 - VAL A 66 MODEL 3 OMEGA = 210.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
74: ASP B 3 - ASP B 4 MODEL 3 OMEGA = 139.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
75: HIS B 6 - PHE B 7 MODEL 3 OMEGA = 120.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
76: PHE B 9 - ARG B 10 MODEL 3 OMEGA = 236.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
77: SER B 29 - MET B 30 MODEL 3 OMEGA = 222.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
78: ASN B 31 - SER B 32 MODEL 3 OMEGA = 145.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
79: PRO B 45 - SER B 46 MODEL 3 OMEGA = 145.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
80: VAL B 48 - THR B 49 MODEL 3 OMEGA = 2.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
81: GLY B 50 - TYR B 51 MODEL 3 OMEGA = 216.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
82: ASN B 53 - ASP B 54 MODEL 3 OMEGA = 345.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
83: ALA B 55 - GLU B 56 MODEL 3 OMEGA = 110.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
84: LEU B 58 - ALA B 59 MODEL 3 OMEGA = 135.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
85: HIS A 6 - PHE A 7 MODEL 4 OMEGA = 113.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
86: PHE A 9 - ARG A 10 MODEL 4 OMEGA = 240.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
87: SER A 29 - MET A 30 MODEL 4 OMEGA = 233.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
88: ASN A 31 - SER A 32 MODEL 4 OMEGA = 149.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
89: SER A 43 - LYS A 44 MODEL 4 OMEGA = 254.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
90: CIS PROLINE - PRO A 47 MODEL 4
91: GLY A 50 - TYR A 51 MODEL 4 OMEGA = 349.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
92: TYR A 51 - ARG A 52 MODEL 4 OMEGA = 231.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
93: ASN A 53 - ASP A 54 MODEL 4 OMEGA = 261.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
94: ASP A 54 - ALA A 55 MODEL 4 OMEGA = 9.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
95: ALA A 55 - GLU A 56 MODEL 4 OMEGA = 100.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
96: ARG A 57 - LEU A 58 MODEL 4 OMEGA = 127.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
97: ASP A 60 - GLU A 61 MODEL 4 OMEGA = 149.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
98: SER A 63 - GLU A 64 MODEL 4 OMEGA = 101.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
99: ALA B 1 - ARG B 2 MODEL 4 OMEGA = 349.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
100: PHE B 9 - ARG B 10 MODEL 4 OMEGA = 348.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
101: SER B 29 - MET B 30 MODEL 4 OMEGA = 216.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
102: ASN B 31 - SER B 32 MODEL 4 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
103: GLY B 50 - TYR B 51 MODEL 4 OMEGA = 148.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
104: ARG B 52 - ASN B 53 MODEL 4 OMEGA = 343.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
105: ASN B 53 - ASP B 54 MODEL 4 OMEGA = 353.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
106: ASP B 54 - ALA B 55 MODEL 4 OMEGA = 116.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
107: ALA B 55 - GLU B 56 MODEL 4 OMEGA = 123.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
108: LEU B 58 - ALA B 59 MODEL 4 OMEGA = 132.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
109: ASP B 60 - GLU B 61 MODEL 4 OMEGA = 138.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
110: GLN B 62 - SER B 63 MODEL 4 OMEGA = 69.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
111: SER B 63 - GLU B 64 MODEL 4 OMEGA = 245.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
112: GLU B 64 - LEU B 65 MODEL 4 OMEGA = 247.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
113: ALA A 1 - ARG A 2 MODEL 5 OMEGA = 351.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
114: HIS A 6 - PHE A 7 MODEL 5 OMEGA = 117.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
115: PHE A 9 - ARG A 10 MODEL 5 OMEGA = 243.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
116: MET A 11 - PRO A 12 MODEL 5 OMEGA = 133.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
117: SER A 29 - MET A 30 MODEL 5 OMEGA = 219.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
118: ASN A 31 - SER A 32 MODEL 5 OMEGA = 142.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
119: ASP A 40 - ALA A 41 MODEL 5 OMEGA = 210.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
120: ALA A 41 - LEU A 42 MODEL 5 OMEGA = 147.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
121: PRO A 45 - SER A 46 MODEL 5 OMEGA = 35.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
122: PRO A 47 - VAL A 48 MODEL 5 OMEGA = 30.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
123: THR A 49 - GLY A 50 MODEL 5 OMEGA = 212.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
124: GLY A 50 - TYR A 51 MODEL 5 OMEGA = 356.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
125: ARG A 52 - ASN A 53 MODEL 5 OMEGA = 131.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
126: ASP A 54 - ALA A 55 MODEL 5 OMEGA = 94.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
127: LEU A 58 - ALA A 59 MODEL 5 OMEGA = 146.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
128: SER A 63 - GLU A 64 MODEL 5 OMEGA = 110.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
129: ASP B 3 - ASP B 4 MODEL 5 OMEGA = 42.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
130: HIS B 6 - PHE B 7 MODEL 5 OMEGA = 144.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
131: PHE B 9 - ARG B 10 MODEL 5 OMEGA = 347.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
132: SER B 29 - MET B 30 MODEL 5 OMEGA = 219.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
133: ASN B 31 - SER B 32 MODEL 5 OMEGA = 144.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
134: PRO B 45 - SER B 46 MODEL 5 OMEGA = 114.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
135: ARG B 52 - ASN B 53 MODEL 5 OMEGA = 347.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
136: ASP B 54 - ALA B 55 MODEL 5 OMEGA = 108.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
137: LEU B 58 - ALA B 59 MODEL 5 OMEGA = 133.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
138: GLU B 64 - LEU B 65 MODEL 5 OMEGA = 144.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
139: HIS A 6 - PHE A 7 MODEL 6 OMEGA = 135.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
140: PHE A 9 - ARG A 10 MODEL 6 OMEGA = 350.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
141: SER A 29 - MET A 30 MODEL 6 OMEGA = 216.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
142: ASN A 31 - SER A 32 MODEL 6 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
143: PRO A 45 - SER A 46 MODEL 6 OMEGA = 48.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
144: ARG A 52 - ASN A 53 MODEL 6 OMEGA = 22.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
145: ASN A 53 - ASP A 54 MODEL 6 OMEGA = 6.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
146: ASP A 54 - ALA A 55 MODEL 6 OMEGA = 125.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
147: ALA A 55 - GLU A 56 MODEL 6 OMEGA = 129.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
148: ARG A 57 - LEU A 58 MODEL 6 OMEGA = 144.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
149: LEU A 58 - ALA A 59 MODEL 6 OMEGA = 135.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
150: ALA A 59 - ASP A 60 MODEL 6 OMEGA = 138.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
151: SER A 63 - GLU A 64 MODEL 6 OMEGA = 133.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
152: ASP B 4 - PRO B 5 MODEL 6 OMEGA = 89.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
153: PRO B 5 - HIS B 6 MODEL 6 OMEGA = 210.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
154: HIS B 6 - PHE B 7 MODEL 6 OMEGA = 128.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
155: SER B 29 - MET B 30 MODEL 6 OMEGA = 215.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
156: ASN B 31 - SER B 32 MODEL 6 OMEGA = 148.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
157: ALA B 41 - LEU B 42 MODEL 6 OMEGA = 143.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
158: LYS B 44 - PRO B 45 MODEL 6 OMEGA = 223.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
159: PRO B 45 - SER B 46 MODEL 6 OMEGA = 120.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
160: VAL B 48 - THR B 49 MODEL 6 OMEGA = 11.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
161: GLY B 50 - TYR B 51 MODEL 6 OMEGA = 347.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
162: ASN B 53 - ASP B 54 MODEL 6 OMEGA = 135.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
163: ASP B 54 - ALA B 55 MODEL 6 OMEGA = 136.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
164: ALA B 55 - GLU B 56 MODEL 6 OMEGA = 113.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
165: LEU B 58 - ALA B 59 MODEL 6 OMEGA = 131.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
166: SER B 63 - GLU B 64 MODEL 6 OMEGA = 144.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
167: HIS A 6 - PHE A 7 MODEL 7 OMEGA = 115.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
168: PHE A 9 - ARG A 10 MODEL 7 OMEGA = 220.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
169: SER A 29 - MET A 30 MODEL 7 OMEGA = 222.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
170: ASN A 31 - SER A 32 MODEL 7 OMEGA = 143.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
171: GLN A 39 - ASP A 40 MODEL 7 OMEGA = 149.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
172: LEU A 42 - SER A 43 MODEL 7 OMEGA = 148.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
173: SER A 43 - LYS A 44 MODEL 7 OMEGA = 242.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
174: VAL A 48 - THR A 49 MODEL 7 OMEGA = 18.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
175: ARG A 52 - ASN A 53 MODEL 7 OMEGA = 341.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
176: ASP A 54 - ALA A 55 MODEL 7 OMEGA = 144.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
177: ALA A 55 - GLU A 56 MODEL 7 OMEGA = 113.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
178: LEU A 58 - ALA A 59 MODEL 7 OMEGA = 145.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
179: SER A 63 - GLU A 64 MODEL 7 OMEGA = 111.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
180: PHE B 9 - ARG B 10 MODEL 7 OMEGA = 340.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
181: SER B 29 - MET B 30 MODEL 7 OMEGA = 216.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
182: ASN B 31 - SER B 32 MODEL 7 OMEGA = 147.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
183: LEU B 42 - SER B 43 MODEL 7 OMEGA = 148.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
184: PRO B 45 - SER B 46 MODEL 7 OMEGA = 138.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
185: VAL B 48 - THR B 49 MODEL 7 OMEGA = 347.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
186: GLY B 50 - TYR B 51 MODEL 7 OMEGA = 4.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
187: ASN B 53 - ASP B 54 MODEL 7 OMEGA = 145.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
188: ASP B 54 - ALA B 55 MODEL 7 OMEGA = 141.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
189: ALA B 55 - GLU B 56 MODEL 7 OMEGA = 137.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
190: LEU B 58 - ALA B 59 MODEL 7 OMEGA = 120.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
191: SER B 63 - GLU B 64 MODEL 7 OMEGA = 123.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
192: ASP A 3 - ASP A 4 MODEL 8 OMEGA = 27.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
193: HIS A 6 - PHE A 7 MODEL 8 OMEGA = 135.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
194: PHE A 9 - ARG A 10 MODEL 8 OMEGA = 235.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
195: ARG A 16 - GLU A 17 MODEL 8 OMEGA = 119.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
196: ALA A 25 - ASN A 26 MODEL 8 OMEGA = 213.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
197: SER A 29 - MET A 30 MODEL 8 OMEGA = 220.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
198: ASN A 31 - SER A 32 MODEL 8 OMEGA = 147.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
199: SER A 43 - LYS A 44 MODEL 8 OMEGA = 234.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
200: LYS A 44 - PRO A 45 MODEL 8 OMEGA = 228.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
201: PRO A 45 - SER A 46 MODEL 8 OMEGA = 133.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
202: VAL A 48 - THR A 49 MODEL 8 OMEGA = 345.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
203: THR A 49 - GLY A 50 MODEL 8 OMEGA = 148.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
204: ASN A 53 - ASP A 54 MODEL 8 OMEGA = 345.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
205: ASP A 54 - ALA A 55 MODEL 8 OMEGA = 251.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
206: ALA A 55 - GLU A 56 MODEL 8 OMEGA = 90.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
207: ARG A 57 - LEU A 58 MODEL 8 OMEGA = 144.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
208: LEU A 58 - ALA A 59 MODEL 8 OMEGA = 148.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
209: SER A 63 - GLU A 64 MODEL 8 OMEGA = 109.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
210: HIS B 6 - PHE B 7 MODEL 8 OMEGA = 129.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
211: ARG B 10 - MET B 11 MODEL 8 OMEGA = 63.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
212: MET B 11 - PRO B 12 MODEL 8 OMEGA = 147.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
213: SER B 29 - MET B 30 MODEL 8 OMEGA = 224.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
214: ASN B 31 - SER B 32 MODEL 8 OMEGA = 145.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
215: PRO B 45 - SER B 46 MODEL 8 OMEGA = 141.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
216: VAL B 48 - THR B 49 MODEL 8 OMEGA = 337.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
217: ARG B 52 - ASN B 53 MODEL 8 OMEGA = 3.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
218: ASN B 53 - ASP B 54 MODEL 8 OMEGA = 211.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
219: ASP B 54 - ALA B 55 MODEL 8 OMEGA = 41.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
220: ALA B 55 - GLU B 56 MODEL 8 OMEGA = 139.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
221: ARG B 57 - LEU B 58 MODEL 8 OMEGA = 144.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
222: LEU B 58 - ALA B 59 MODEL 8 OMEGA = 131.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
223: ASP B 60 - GLU B 61 MODEL 8 OMEGA = 145.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
224: GLU B 64 - LEU B 65 MODEL 8 OMEGA = 143.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
225: PRO A 5 - HIS A 6 MODEL 9 OMEGA = 215.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
226: ASN A 8 - PHE A 9 MODEL 9 OMEGA = 147.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
227: PHE A 9 - ARG A 10 MODEL 9 OMEGA = 235.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
228: ARG A 10 - MET A 11 MODEL 9 OMEGA = 210.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
229: SER A 29 - MET A 30 MODEL 9 OMEGA = 213.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
230: ASN A 31 - SER A 32 MODEL 9 OMEGA = 143.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
231: LYS A 44 - PRO A 45 MODEL 9 OMEGA = 75.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
232: ASN A 53 - ASP A 54 MODEL 9 OMEGA = 230.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
233: ASP A 54 - ALA A 55 MODEL 9 OMEGA = 225.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
234: GLU A 56 - ARG A 57 MODEL 9 OMEGA = 264.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
235: LEU A 58 - ALA A 59 MODEL 9 OMEGA = 132.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
236: ASP A 60 - GLU A 61 MODEL 9 OMEGA = 116.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
237: SER A 63 - GLU A 64 MODEL 9 OMEGA = 104.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
238: ARG B 2 - ASP B 3 MODEL 9 OMEGA = 147.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
239: HIS B 6 - PHE B 7 MODEL 9 OMEGA = 147.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
240: PHE B 9 - ARG B 10 MODEL 9 OMEGA = 230.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
241: SER B 29 - MET B 30 MODEL 9 OMEGA = 220.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
242: ASN B 31 - SER B 32 MODEL 9 OMEGA = 146.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
243: SER B 43 - LYS B 44 MODEL 9 OMEGA = 145.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
244: CIS PROLINE - PRO B 47 MODEL 9
245: PRO B 47 - VAL B 48 MODEL 9 OMEGA = 143.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
246: VAL B 48 - THR B 49 MODEL 9 OMEGA = 216.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
247: ASN B 53 - ASP B 54 MODEL 9 OMEGA = 293.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
248: ALA B 55 - GLU B 56 MODEL 9 OMEGA = 24.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
249: LEU B 58 - ALA B 59 MODEL 9 OMEGA = 147.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
250: ASP B 60 - GLU B 61 MODEL 9 OMEGA = 138.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
251: SER B 63 - GLU B 64 MODEL 9 OMEGA = 112.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
252: PHE A 9 - ARG A 10 MODEL 10 OMEGA = 342.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
253: SER A 29 - MET A 30 MODEL 10 OMEGA = 211.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
254: ASN A 31 - SER A 32 MODEL 10 OMEGA = 146.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
255: CIS PROLINE - PRO A 45 MODEL 10
256: PRO A 45 - SER A 46 MODEL 10 OMEGA = 133.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
257: ASN A 53 - ASP A 54 MODEL 10 OMEGA = 146.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
258: ALA A 55 - GLU A 56 MODEL 10 OMEGA = 100.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
259: LEU A 58 - ALA A 59 MODEL 10 OMEGA = 132.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
260: PHE B 9 - ARG B 10 MODEL 10 OMEGA = 237.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
261: SER B 29 - MET B 30 MODEL 10 OMEGA = 213.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
262: PRO B 45 - SER B 46 MODEL 10 OMEGA = 137.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
263: ASN B 53 - ASP B 54 MODEL 10 OMEGA = 262.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
264: ASP B 54 - ALA B 55 MODEL 10 OMEGA = 229.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
265: ALA B 55 - GLU B 56 MODEL 10 OMEGA = 92.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
266: LEU B 58 - ALA B 59 MODEL 10 OMEGA = 142.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
267: SER B 63 - GLU B 64 MODEL 10 OMEGA = 94.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
268: GLU B 64 - LEU B 65 MODEL 10 OMEGA = 214.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
269: LEU B 65 - VAL B 66 MODEL 10 OMEGA = 146.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
270: HIS A 6 - PHE A 7 MODEL 11 OMEGA = 142.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
271: SER A 29 - MET A 30 MODEL 11 OMEGA = 221.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
272: ASN A 31 - SER A 32 MODEL 11 OMEGA = 143.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
273: PRO A 45 - SER A 46 MODEL 11 OMEGA = 130.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
274: ARG A 52 - ASN A 53 MODEL 11 OMEGA = 33.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
275: ASN A 53 - ASP A 54 MODEL 11 OMEGA = 140.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
276: ASP A 54 - ALA A 55 MODEL 11 OMEGA = 140.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
277: ALA A 55 - GLU A 56 MODEL 11 OMEGA = 129.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
278: LEU A 58 - ALA A 59 MODEL 11 OMEGA = 139.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
279: ALA A 59 - ASP A 60 MODEL 11 OMEGA = 141.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
280: ASP A 60 - GLU A 61 MODEL 11 OMEGA = 129.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
281: GLU A 64 - LEU A 65 MODEL 11 OMEGA = 148.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
282: PHE B 9 - ARG B 10 MODEL 11 OMEGA = 229.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
283: PRO B 12 - MET B 13 MODEL 11 OMEGA = 213.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
284: SER B 29 - MET B 30 MODEL 11 OMEGA = 215.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
285: ASN B 31 - SER B 32 MODEL 11 OMEGA = 148.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
286: VAL B 38 - GLN B 39 MODEL 11 OMEGA = 149.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
287: CIS PROLINE - PRO B 47 MODEL 11
288: PRO B 47 - VAL B 48 MODEL 11 OMEGA = 141.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
289: GLY B 50 - TYR B 51 MODEL 11 OMEGA = 343.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
290: ASN B 53 - ASP B 54 MODEL 11 OMEGA = 12.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
291: ALA B 55 - GLU B 56 MODEL 11 OMEGA = 94.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
292: LEU B 58 - ALA B 59 MODEL 11 OMEGA = 137.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
293: SER B 63 - GLU B 64 MODEL 11 OMEGA = 121.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
294: LEU B 65 - VAL B 66 MODEL 11 OMEGA = 143.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
295: HIS A 6 - PHE A 7 MODEL 12 OMEGA = 146.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
296: PHE A 9 - ARG A 10 MODEL 12 OMEGA = 213.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
297: ARG A 10 - MET A 11 MODEL 12 OMEGA = 211.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
298: ASN A 31 - SER A 32 MODEL 12 OMEGA = 142.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
299: LYS A 44 - PRO A 45 MODEL 12 OMEGA = 220.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
300: PRO A 45 - SER A 46 MODEL 12 OMEGA = 128.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
301: ASN A 53 - ASP A 54 MODEL 12 OMEGA = 3.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
302: ALA A 55 - GLU A 56 MODEL 12 OMEGA = 107.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
303: LEU A 58 - ALA A 59 MODEL 12 OMEGA = 138.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
304: PRO B 5 - HIS B 6 MODEL 12 OMEGA = 210.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
305: PHE B 9 - ARG B 10 MODEL 12 OMEGA = 212.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
306: SER B 29 - MET B 30 MODEL 12 OMEGA = 212.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
307: ASN B 31 - SER B 32 MODEL 12 OMEGA = 144.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
308: LEU B 42 - SER B 43 MODEL 12 OMEGA = 107.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
309: VAL B 48 - THR B 49 MODEL 12 OMEGA = 346.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
310: ASN B 53 - ASP B 54 MODEL 12 OMEGA = 148.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
311: ASP B 54 - ALA B 55 MODEL 12 OMEGA = 83.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
312: ALA B 55 - GLU B 56 MODEL 12 OMEGA = 148.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
313: LEU B 58 - ALA B 59 MODEL 12 OMEGA = 141.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
314: ASP B 60 - GLU B 61 MODEL 12 OMEGA = 145.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
315: SER B 63 - GLU B 64 MODEL 12 OMEGA = 125.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
316: HIS A 6 - PHE A 7 MODEL 13 OMEGA = 144.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
317: PHE A 9 - ARG A 10 MODEL 13 OMEGA = 217.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
318: SER A 29 - MET A 30 MODEL 13 OMEGA = 215.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
319: ASN A 31 - SER A 32 MODEL 13 OMEGA = 148.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
320: SER A 43 - LYS A 44 MODEL 13 OMEGA = 238.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
321: ASN A 53 - ASP A 54 MODEL 13 OMEGA = 115.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
322: LEU A 58 - ALA A 59 MODEL 13 OMEGA = 148.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
323: ALA A 59 - ASP A 60 MODEL 13 OMEGA = 144.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
324: ASP A 60 - GLU A 61 MODEL 13 OMEGA = 91.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
325: GLU A 61 - GLN A 62 MODEL 13 OMEGA = 102.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
326: SER A 63 - GLU A 64 MODEL 13 OMEGA = 106.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
327: HIS B 6 - PHE B 7 MODEL 13 OMEGA = 146.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
328: PHE B 9 - ARG B 10 MODEL 13 OMEGA = 224.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
329: SER B 29 - MET B 30 MODEL 13 OMEGA = 218.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
330: LYS B 44 - PRO B 45 MODEL 13 OMEGA = 218.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
331: PRO B 45 - SER B 46 MODEL 13 OMEGA = 141.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
332: VAL B 48 - THR B 49 MODEL 13 OMEGA = 227.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
333: GLY B 50 - TYR B 51 MODEL 13 OMEGA = 22.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
334: ASP B 54 - ALA B 55 MODEL 13 OMEGA = 232.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
335: ALA B 55 - GLU B 56 MODEL 13 OMEGA = 123.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
336: LEU B 58 - ALA B 59 MODEL 13 OMEGA = 127.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
337: ASP B 60 - GLU B 61 MODEL 13 OMEGA = 129.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
338: GLU B 64 - LEU B 65 MODEL 13 OMEGA = 147.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
339: PHE A 9 - ARG A 10 MODEL 14 OMEGA = 218.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
340: SER A 29 - MET A 30 MODEL 14 OMEGA = 213.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
341: ASN A 31 - SER A 32 MODEL 14 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
342: LYS A 44 - PRO A 45 MODEL 14 OMEGA = 237.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
343: PRO A 45 - SER A 46 MODEL 14 OMEGA = 127.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
344: VAL A 48 - THR A 49 MODEL 14 OMEGA = 210.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
345: ASN A 53 - ASP A 54 MODEL 14 OMEGA = 226.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
346: ASP A 54 - ALA A 55 MODEL 14 OMEGA = 284.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
347: GLU A 56 - ARG A 57 MODEL 14 OMEGA = 254.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
348: ARG A 57 - LEU A 58 MODEL 14 OMEGA = 301.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
349: ALA A 59 - ASP A 60 MODEL 14 OMEGA = 219.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
350: ASP A 60 - GLU A 61 MODEL 14 OMEGA = 221.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
351: GLU A 61 - GLN A 62 MODEL 14 OMEGA = 86.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
352: SER A 63 - GLU A 64 MODEL 14 OMEGA = 44.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
353: PRO B 12 - MET B 13 MODEL 14 OMEGA = 210.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
354: ASN B 26 - GLY B 27 MODEL 14 OMEGA = 211.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
355: SER B 29 - MET B 30 MODEL 14 OMEGA = 213.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
356: ASN B 31 - SER B 32 MODEL 14 OMEGA = 145.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
357: LYS B 44 - PRO B 45 MODEL 14 OMEGA = 137.76 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
358: CIS PROLINE - PRO B 47 MODEL 14
359: GLY B 50 - TYR B 51 MODEL 14 OMEGA = 0.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
360: ASP B 54 - ALA B 55 MODEL 14 OMEGA = 62.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
361: GLU B 56 - ARG B 57 MODEL 14 OMEGA = 111.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
362: ARG B 57 - LEU B 58 MODEL 14 OMEGA = 216.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
363: LEU B 58 - ALA B 59 MODEL 14 OMEGA = 123.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
364: ALA B 59 - ASP B 60 MODEL 14 OMEGA = 216.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
365: ASP B 60 - GLU B 61 MODEL 14 OMEGA = 257.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
366: GLN B 62 - SER B 63 MODEL 14 OMEGA = 273.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
367: SER B 63 - GLU B 64 MODEL 14 OMEGA = 119.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
368: GLU B 64 - LEU B 65 MODEL 14 OMEGA = 146.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
369: HIS A 6 - PHE A 7 MODEL 15 OMEGA = 147.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
370: ARG A 10 - MET A 11 MODEL 15 OMEGA = 217.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
371: SER A 29 - MET A 30 MODEL 15 OMEGA = 213.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
372: ASN A 31 - SER A 32 MODEL 15 OMEGA = 145.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
373: LYS A 44 - PRO A 45 MODEL 15 OMEGA = 211.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
374: PRO A 45 - SER A 46 MODEL 15 OMEGA = 134.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
375: VAL A 48 - THR A 49 MODEL 15 OMEGA = 232.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
376: GLY A 50 - TYR A 51 MODEL 15 OMEGA = 358.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
377: ASN A 53 - ASP A 54 MODEL 15 OMEGA = 357.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
378: ALA A 55 - GLU A 56 MODEL 15 OMEGA = 121.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
379: LEU A 58 - ALA A 59 MODEL 15 OMEGA = 117.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
380: ASP A 60 - GLU A 61 MODEL 15 OMEGA = 133.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
381: GLU A 61 - GLN A 62 MODEL 15 OMEGA = 145.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
382: SER A 63 - GLU A 64 MODEL 15 OMEGA = 143.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
383: GLU A 64 - LEU A 65 MODEL 15 OMEGA = 148.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
384: HIS B 6 - PHE B 7 MODEL 15 OMEGA = 149.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
385: PHE B 9 - ARG B 10 MODEL 15 OMEGA = 236.01 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
386: LYS B 20 - PHE B 21 MODEL 15 OMEGA = 148.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
387: SER B 29 - MET B 30 MODEL 15 OMEGA = 218.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
388: ASN B 31 - SER B 32 MODEL 15 OMEGA = 149.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
389: LYS B 44 - PRO B 45 MODEL 15 OMEGA = 143.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
390: TYR B 51 - ARG B 52 MODEL 15 OMEGA = 149.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
391: ARG B 52 - ASN B 53 MODEL 15 OMEGA = 16.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
392: ASP B 54 - ALA B 55 MODEL 15 OMEGA = 142.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
393: ALA B 55 - GLU B 56 MODEL 15 OMEGA = 120.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
394: LEU B 58 - ALA B 59 MODEL 15 OMEGA = 143.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
395: SER B 63 - GLU B 64 MODEL 15 OMEGA = 77.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
NMR アンサンブル
データ基準
コンフォーマー数 (登録 / 計算)15 / -
代表モデル

-
要素

#1: タンパク質 MNT REPRESSOR


分子量: 8826.000 Da / 分子数: 2 / 由来タイプ: 組換発現
由来: (組換発現) Enterobacteria phage P22 (ファージ)
: P22-like viruses / 参照: UniProt: P03049

-
実験情報

-
実験

実験手法: 溶液NMR

-
試料調製

結晶化
*PLUS
手法: other / 詳細: NMR

-
解析

NMRアンサンブル登録したコンフォーマーの数: 15

+
万見について

-
お知らせ

-
2022年2月9日: EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

  • EMDBのヘッダファイルのバージョン3が、公式のフォーマットとなりました。
  • これまでは公式だったバージョン1.9は、アーカイブから削除されます。

関連情報:EMDBヘッダ

外部リンク:wwPDBはEMDBデータモデルのバージョン3へ移行します

-
2020年8月12日: 新型コロナ情報

新型コロナ情報

URL: https://pdbj.org/emnavi/covid19.php

新ページ: EM Navigatorに新型コロナウイルスの特設ページを開設しました。

関連情報:Covid-19情報 / 2020年3月5日: 新型コロナウイルスの構造データ

+
2020年3月5日: 新型コロナウイルスの構造データ

新型コロナウイルスの構造データ

関連情報:万見生物種 / 2020年8月12日: 新型コロナ情報

外部リンク:COVID-19特集ページ - PDBj / 今月の分子2020年2月:コロナウイルスプロテーアーゼ

+
2019年1月31日: EMDBのIDの桁数の変更

EMDBのIDの桁数の変更

  • EMDBエントリに付与されているアクセスコード(EMDB-ID)は4桁の数字(例、EMD-1234)でしたが、間もなく枯渇します。これまでの4桁のID番号は4桁のまま変更されませんが、4桁の数字を使い切った後に発行されるIDは5桁以上の数字(例、EMD-12345)になります。5桁のIDは2019年の春頃から発行される見通しです。
  • EM Navigator/万見では、接頭語「EMD-」は省略されています。

関連情報:Q: 「EMD」とは何ですか? / 万見/EM NavigatorにおけるID/アクセスコードの表記

外部リンク:EMDB Accession Codes are Changing Soon! / PDBjへお問い合わせ

+
2017年7月12日: PDB大規模アップデート

PDB大規模アップデート

  • 新バージョンのPDBx/mmCIF辞書形式に基づくデータがリリースされました。
  • 今回の更新はバージョン番号が4から5になる大規模なもので、全エントリデータの書き換えが行われる「Remediation」というアップデートに該当します。
  • このバージョンアップで、電子顕微鏡の実験手法に関する多くの項目の書式が改定されました(例:em_softwareなど)。
  • EM NavigatorとYorodumiでも、この改定に基づいた表示内容になります。

外部リンク:wwPDB Remediation / OneDepデータ基準に準拠した、より強化された内容のモデル構造ファイルが、PDBアーカイブで公開されました。

-
万見 (Yorodumi)

幾万の構造データを、幾万の視点から

  • 万見(Yorodumi)は、EMDB/PDB/SASBDBなどの構造データを閲覧するためのページです。
  • EM Navigatorの詳細ページの後継、Omokage検索のフロントエンドも兼ねています。

関連情報:EMDB / PDB / SASBDB / 3つのデータバンクの比較 / 万見検索 / 2016年8月31日: 新しいEM Navigatorと万見 / 万見文献 / Jmol/JSmol / 機能・相同性情報 / 新しいEM Navigatorと万見の変更点

他の情報も見る